FindTrial
Sign In

Patterns Of Haematological Biomarker in cervical cancer patients and its association with its covariates

Assessment Of Pre-treatment Neutrophil Lymphocyte Ratio Among Cervical Cancer Patients And Its Association with Stages Of Cervical Cancer (FIGO), Sociodemographic, Lifestyle And Reproductive Factors.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/06/053636
Enrollment
139
Registered
2023-06-07
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified

Interventions

None listed

Sponsors

Vardhman Mahavir Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with positive biopsy report of cervical carcinoma at any stage of the disease

Exclusion criteria

Exclusion criteria: Patients who donâ??t have a record of their Pre Treatment Neutrophil lymphocyte Ratio (NLR). Severely ill patients not able to converse. Patients suffering from sepsis. Patients with a positive biopsy for blood cancer. Patients with a history of tuberculosis. Patients with severe wounds. Any other severe inflammation except cervical cancer. Patients with active liver disease, including those with primary biliary cirrhosis and unexplained persistent liver function abnormalities. Any medication or indication that may interfere with the interpretation of study results and, in the judgment of the study personnel, would make the subject inappropriate for inclusion. Patients with history of severe allergies.

Design outcomes

Primary

MeasureTime frame
To find mean Neutrophil Lymphocyte Ratio(NLR) among cervical cancer patients.Timepoint: 9 weeks—

Secondary

MeasureTime frame
To check association of Neutrophil Lymphocyte Ratio(NLR) with Sociodemographic, lifestyle & reproductive factors among cervical cancer patients.Timepoint: 9 weeks;To compare Neutrophil Lymphocyte Ratio(NLR) among various stages of cervical cancer.Timepoint: 9 weeks—

Countries

India

Contacts

Public ContactPranavraj Singh Rathore

VMMC, Safdarjung Hospital

swapnilsharma462@gmail.com8707603658

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026